Thus, phenobarbital-induced aggravation of fatty liver in HFD obese rats [180] might have been induced, at least in part, by the exacerbation of NAFLD-related CYP2E1 induction. This evidence concerns the gene CYP2E1 and metabolic dysfunction-associated steatotic liver disease.